EUVIMEDEUVIMED entdecken
Vergleichsstudie

Carotid disease treatment modality and its association with postoperative vasoactive medication utilization and hospital length of stay

Nicholas E Olin, Jaclyn N Corso, Yiik Law, David K Yi, Su-Jau Yang, Andrew Son

Journal of Vascular Surgery · 2025

DOI: 10.1016/j.jvs.2025.01.193 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Vascular Surgery, 2025. Verfasst von Nicholas E Olin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Riverside University Health System, Moreno Valley, CA; Department of Vascular Surgery, Southern California Permanente Medical …. Hauptthemen laut MEDLINE: Length of Stay, Vasoconstrictor Agents, Endarterectomy, Carotid, Vasodilator Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Gefördert von: Kaiser Permanente LLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Carotid artery disease is a major cause of stroke for which the standard treatment has traditionally been a combination of medical management and intervention, including carotid endarterectomy (CEA) and transfemoral carotid artery stenting (TFCAS). In recent years, transcarotid artery revascularization (TCAR) has been adopted as a promising treatment after US Food and Drug Administration approval in 2015. In terms of stroke reduction, TCAR has been found to have equivalent outcomes with CEA with shorter operative times. A well-described side effect of TCAR is the stimulation of baroreceptors in the carotid bulb, resulting in bradycardia and blood pressure variability that may require vasopressor support. This factor has the potential to lengthen both intensive care unit (ICU) and entire hospital stay. The goal of this retrospective cohort study was to determine whether there is a difference in postoperative vasopressor or vasodilator treatment between traditional CEA, TFCAS, or TCAR and whether it affects ICU and/or overall hospital lengths of stay. METHODS: The Kaiser Permanente Southern California regional database was queried from January 2018 to December 2023 for all patients who underwent CEA, TFCAS, or TCAR at any Southern California Permanente Hospital. The χ2 and Kruskal-Wallis tests were used to analyze patient characteristics and compare medication use and ICU and postintervention length of stay in each intervention modality. RESULTS: The regional database query yielded 3012 patients who had undergone CEA, TFCAS, or TCAR. The average postoperative inpatient length of stay for TCAR patients (2.8 days) was shorter than CEA (3.7 days) and TFCAS (5.6 days) (P < .0001). TCAR patients were more likely to have intravenous vasoactive medication (21.0%) compared with CEA (6.2%) and TFCAS (7.7%) (P < .0001). Also, TCAR patients were more likely to have oral midodrine prescribed at any point in their hospitalization (9.1%) compared with CEA (0.5%) and TFCAS (2.0%) (P < .001). CONCLUSIONS: TCAR patients were more likely to require intavenous vasoactive medication postoperatively compared with CEA and TFCAS patients. This finding is likely secondary to baroreceptor stimulation by balloon angioplasty and stent deployment. Further investigation to analyze why this is not as frequently seen with TFCAS would be beneficial. Despite this, TCAR had lower postoperative ICU and hospital lengths of stay. Combining these findings with already reported benefits makes TCAR an attractive option in the operative treatment of carotid artery stenosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Length of StayVasoconstrictor AgentsEndarterectomy, CarotidVasodilator AgentsCarotid Artery DiseasesEndovascular ProceduresHumansRetrospective StudiesFemaleMaleAgedMiddle AgedTreatment OutcomeTime FactorsDatabases, FactualStentsAged, 80 and overRisk FactorsCaliforniaIntensive Care Units

Stichwörter der Autor:innen

Carotid artery stenosisCarotid endarterectomyTranscarotid artery stentingTransfemoral carotid artery stenting

Substanzen

Vasoconstrictor AgentsVasodilator Agents

Autor:innen und Institutionen

  • Department of Surgery, Riverside University Health System, Moreno Valley, CA; Department of Vascular Surgery, Southern California Permanente Medical Group, Kaiser Permanente, Riverside, CA. Electronic address: nicholase…
  • Department of Surgery, Riverside University Health System, Moreno Valley, CA; Department of Vascular Surgery, Southern California Permanente Medical Group, Kaiser Permanente, Riverside, CA.
  • Department of Vascular Surgery, Southern California Permanente Medical Group, Kaiser Permanente, Riverside, CA.
  • Department of Research and Evaluation, Kaiser Permanente, Riverside, CA.
  • Department of Vascular Surgery, Southern California Permanente Medical Group, Kaiser Permanente, Riverside, CA; University of California, Riverside School of Medicine, Riverside, CA.

Förderung

  • Kaiser Permanente LLC

Zitieren

APA

Olin, N. E., Corso, J. N., Law, Y., Yi, D. K., Yang, S. J., & Son, A. (2025). Carotid disease treatment modality and its association with postoperative vasoactive medication utilization and hospital length of stay. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2025.01.193

Vancouver

Olin NE, Corso JN, Law Y, Yi DK, Yang SJ, Son A. Carotid disease treatment modality and its association with postoperative vasoactive medication utilization and hospital length of stay. Journal of Vascular Surgery. 2025. doi:10.1016/j.jvs.2025.01.193

BibTeX
@article{Olin2025,
  author = {Olin, Nicholas E and Corso, Jaclyn N and Law, Yiik and Yi, David K and Yang, Su-Jau and Son, Andrew},
  title = {Carotid disease treatment modality and its association with postoperative vasoactive medication utilization and hospital length of stay},
  journal = {Journal of Vascular Surgery},
  year = {2025},
  doi = {10.1016/j.jvs.2025.01.193}
}
Kostenlos starten →